Group Benefit Billing is now accessible on benefitsConnect OS.
Creating an all-in-one experience for Plan Administrators.
Reach out to your Client Success Represenative for more information.
benefitsConnect Financial Wellness Corner
Will Canadians’ retirement last longer than they planned?
Written by: Freschia Gonzales – Benefits and Pensions Monitor
“Despite economic improvements since April 2023, 34 percent of workers worry about insufficient retirement savings, and only 33 percent have a formal retirement plan. “
Industry Trends
Biosimilar vs. Biologic Prescription Medication
by Jaclyn Dobing – Group Account Manager at benefitsConnect
As we stepped into 2023, a groundbreaking shift began as numerous Provinces embraced biosimilar drug treatments within their healthcare plans. With insurance carriers quickly aligning with this movement, the buzz continues among employees visiting pharmacies. This strategic initiative aims to seamlessly guide members from biologic medications to the innovative world of biosimilars. Many biosimilar medications are more accessible, and cost effective compared to the biologic medications. Resulting in positive impacts for both employees and employers. Biologic vs. Biosimilar
In short terms, biologic medications are made from living cells while biosimilar medications are close in structure to biologic medications.
Reference the Canadian Government website for more information: Biosimilar biologic drugs in Canada: Fact Sheet – Canada.ca
More Industry Trends
Is menopause support in Canada falling short for women over 40?
by: Freschia Gonzales – Benefits Pension Monitor
Employee Perk of the Month
